Brandinium

Trademark search for:

OSTIBONE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-03-30 — Application filed
  • 2010-04-02 — Application filed
  • 2010-04-06 — Application filed
  • 2010-06-06 — Assigned to examiner
  • 2010-06-10 — Final disposition recorded
  • 2010-06-10 — Final disposition recorded
  • 2010-06-10 — Final disposition recorded
  • 2010-10-12 — Paper received
  • 2010-10-22 — Assigned to lie
  • 2010-10-22 — Correspondence received in law office
  • 2010-10-22 — Amendment from applicant entered
  • 2010-11-04 — Assigned to examiner
  • 2010-11-04 — Approved for pub - principal register
  • 2010-11-08 — Law office publication review completed
  • 2010-12-14 — Published for opposition
  • 2010-12-14 — Official gazette publication confirmation e-mailed
  • 2011-01-12 — Opposition papers received at ttab
  • 2011-01-12 — Opposition instituted no. 999999
  • 2011-04-22 — Opposition terminated no. 999999
  • 2011-04-22 — Opposition sustained no. 999999
  • 2011-04-22 — Application abandoned
  • 2011-04-22 — Application abandoned
  • 2011-04-22 — Final status recorded

Owner Information

Schwartz, Claude
Zimmerbach FR
Mainard, Didier
Laxou FR
Schwartz, Claude
Zimmerbach FR
Mainard, Didier
Laxou FR

Correspondent

BROOKS R. BRUNEAU PORZIO BROMBERG & NEWMAN, P.C.
29 THANET RD STE 201
PRINCETON, NJ 08540-3661
UNITED STATES

Filing Details

Filing Date:
2010-03-30
Status Date:
2011-04-22
Category:
Medical Apparatus
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.